ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,732,798 | +54.5% | 84,568 | +49.8% | 0.01% | +66.7% |
Q2 2023 | $1,121,662 | +6.5% | 56,450 | -8.2% | 0.00% | 0.0% |
Q1 2023 | $1,053,564 | +0.8% | 61,504 | +15.1% | 0.00% | 0.0% |
Q4 2022 | $1,045,292 | -25.3% | 53,413 | -39.1% | 0.00% | -25.0% |
Q3 2022 | $1,399,000 | -10.7% | 87,680 | -23.0% | 0.00% | 0.0% |
Q2 2022 | $1,567,000 | +17.5% | 113,903 | +35.4% | 0.00% | +33.3% |
Q1 2022 | $1,334,000 | +9.2% | 84,100 | +50.2% | 0.00% | +50.0% |
Q4 2021 | $1,222,000 | -30.9% | 56,000 | -5.4% | 0.00% | -50.0% |
Q3 2021 | $1,769,000 | -61.6% | 59,200 | -43.1% | 0.00% | -60.0% |
Q2 2021 | $4,606,000 | -0.2% | 103,988 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $4,614,000 | -5.3% | 103,988 | +17.1% | 0.01% | -9.1% |
Q4 2020 | $4,871,000 | +207.5% | 88,819 | +28.2% | 0.01% | +175.0% |
Q3 2020 | $1,584,000 | +61.6% | 69,300 | +48.1% | 0.00% | +33.3% |
Q2 2020 | $980,000 | +32.6% | 46,800 | -11.7% | 0.00% | +50.0% |
Q1 2020 | $739,000 | -27.2% | 53,000 | +18.8% | 0.00% | -33.3% |
Q4 2019 | $1,015,000 | +95.2% | 44,600 | 0.0% | 0.00% | +200.0% |
Q3 2019 | $520,000 | +0.4% | 44,600 | +29.3% | 0.00% | 0.0% |
Q2 2019 | $518,000 | +5.5% | 34,500 | +23.2% | 0.00% | 0.0% |
Q1 2019 | $491,000 | +53.4% | 28,000 | +29.6% | 0.00% | 0.0% |
Q4 2018 | $320,000 | -34.7% | 21,600 | +8.5% | 0.00% | 0.0% |
Q3 2018 | $490,000 | +25.3% | 19,900 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $391,000 | – | 19,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |